Bevonium

Bevonium

SCHEMBL28086190

C1CNCCN1.C[N+]1(C)CCCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Bevonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 11/20 0.47
CHRM3 P20309 11/20 0.47
CHRM1 P11229 5/20 0.47
CYP2D6 P10635 4/20 0.47
CHRM4 P08173 3/20 0.47
CHRM5 P08912 3/20 0.47
KCNH2 Q12809 4/20 0.46
LMNA P02545 2/20 0.46
SLC6A4 P31645 2/20 0.46
CYP2C19 P33261 1/20 0.46
HRH1 P35367 2/20 0.46
SLC22A1 O15245 1/20 0.46
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bevonium SCHEMBL1650540 0.94 CHRM2 (0.51) CHRM2CHRM3CHRM1CYP2D6CHRM4
Poldine SCHEMBL1641786 0.91 CHRM2 (0.55) CHRM2CHRM3CHRM1CYP2D6CHRM4
Bevonium SCHEMBL28439272 0.88 CHRM2 (0.46) CHRM2CHRM3CHRM1CYP2D6CHRM4
Bevonium SCHEMBL25016 0.87 CHRM2 (0.45) CHRM2CHRM3CHRM1CYP2D6CHRM4
Poldine SCHEMBL250977 0.83 CHRM2 (0.48) CHRM2CHRM3CHRM1CYP2D6CHRM4
Oxypyrronium SCHEMBL29388831 0.79 POLB (0.57) CHRM2CHRM3CHRM1CYP2D6CHRM4
Oxypyrronium SCHEMBL916858 0.78 CHRM2 (0.56) CHRM2CHRM3CHRM1CYP2D6CHRM4
Poldine SCHEMBL28086707 0.77 CHRM2 (0.67) CHRM2CHRM3CHRM1CYP2D6CHRM4
SCHEMBL14166722 0.76 CHRM3 (0.63) CHRM2CHRM3CHRM1CYP2D6CHRM4
SCHEMBL1087914 0.73 CHRM2 (0.47) CHRM2CHRM3CHRM1CYP2D6CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed